
What We’re Reading: Weight Loss Results for Mounjaro; 8-Year Drug Shortage; Bacterial Outbreak Kills 4
Type 2 diabetes drug tirzepatide (Mounjaro) helped some individuals lose nearly 16% of their body weight; some vital drugs have been sporadically in shortage for over 8 years; a bacterial outbreak of klebsiella claimed 4 lives and infected 31 people in a Seattle hospital.
Mounjaro Helps Those with T2 Diabetes Lose Weight
Eli Lilly & Co.’s drug tirzepatide (Mounjaro) for type 2 diabetes helped those with the disease who are also overweight or obese lose up to 15.7% of their body weight, in a recent study that could introduce a way for Lilly to promote the drug as a weight-loss medication,
Some Vital Drugs Have Been Short for Over 8 Years
At least 20 vital drugs have been intermittently in shortage since 2015, according to the American Society of Health-System Pharmacists (ASHP) database,
Four Dead in Bacterial Outbreak in Washington
An outbreak of a bacteria usually found in health care settings that has developed resistance to some antibiotics has been connected to 4 deaths in patients at a downtown Seattle hospital,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.